Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMP.L Regulatory News (AMP)

  • There is currently no data for AMP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Partner Company - Product Launch

17 Sep 2008 07:00

RNS Number : 5981D
Amphion Innovations PLC
17 September 2008
 



Amphion Innovations plc Partner Company, Kromek, Confirms the Near Completion of Scanning Systems 

to Enhance Airport Security Procedures

London and New York, 17 September 2008 Amphion Innovations plc (LSE: AMP) ("Amphion" or the "Company"), the developer of companies in the medical and technology sectors, today announces that its Partner Company, Kromek, the developer of digital colour imaging for use in x-rays and scanners, has confirmed it will be launching two products for use in airports in the coming months.

Upcoming products include:

A Threat Liquid Detection system using a digital colour x-ray detector for the rapid identification of liquid inside a bottle, removing the need to open the bottle or sample the liquid. This product will be launched in November in Dubai and in December in Washington and is used for scanning single bottles.

A 311+ Scanner using the same technology to scan for any threat liquids contained in 311 bags (plastic bags which are used for carrying small bottles of liquid in aircrafts). This product will be launched within the next five months.

Kromek is also pioneering the development of 3D, colour x-ray imaging using its unique capability in semiconductors and imaging systems which will significantly enhance the existing baggage screening application. These new baggage screening systems will have the ability to produce 3D images of a bag, giving operators a much better visualization of objects inside and will automatically identify any threat material using new generation detectors and advanced algorithms unique to Kromek.

Kromek is currently carrying out the development of its baggage imaging systems in conjunction with the UK Home office and is in talks with a number of parties for licensing this technology. 

Richard Morgan, Amphion Chief Executive Officer, said "We are pleased to be able to announce the launch of Kromek's first two commercially available products, which is an exciting milestone not only for the company but also for airport security systems worldwide."

Dr Arnab Basu, Chief Executive Officer of Kromek said:

'Kromek is proud to be working alongside bodies such as the UK Home office in the development of scanners for the detection of prohibited liquids. These systems are aimed at enhancing the high levels of security already existing at UK airports, while at the same time greatly adding to passenger convenience and reducing time spent in transit.' 

For further information please contact

Amphion Innovations plc Charlie Morgan, Director of Communications +1 212 210 6224 (New York)

Cardew Group Tim Robertson/ Jamie Milton/ Matthew Law +44 020 7930 0777 (London

Charles Stanley Securities - Nominated Adviser  Mark Taylor / Freddy Crossley +44 20 7149 6000

About Amphion Innovations plc Amphion (LSE: AMP) builds shareholder value in high growth companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK. Amphion has significant shareholding in 10 Partner Companies developing proven technologies targeting substantial commercial marketplaces, each in excess of $1 billion. Each Partner Company is chosen with the goal of achieving an exit valuation in excess of $100 million.

On the web: www.amphionplc.com

About Kromek

Kromek is a venture backed high technology company, which was spun-out in April 2003 as Durham Scientific Crystals, from the Physics Department of the University of Durham. Rebranded as Kromek in May 2008, its pioneering digital colour imaging for x-rays has brought ground-breaking innovation to materials technology and advanced 3D imaging that will literally change the way in which we see the world.

The Company specialises in making semiconductor materials within the Cadmium Telluride family. These materials have significant applications as detectors of x-rays and gamma rays, notably in medical imaging, security screening, industrial inspection and space exploration, allowing for very precise identification of materials. Cadmium Zinc Telluride is also the material of choice as a substrate for the fabrication of infrared detectors in both civilian and military markets. In addition to its range of semiconductor materials, detector packages and non imaging detection systems Kromek also supplies x-ray imaging packages with multi view capabilities. These x-ray display platforms provide real 3D x-ray imaging for the first time without specialist viewing equipment. 

On the web: www.kromek.com 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAUNRBRWURKAAR
Date   Source Headline
1st Jul 20155:07 pmRNSHolding(s) in Company
23rd Jun 20158:47 amRNSPartner Company raises £22 million
23rd Jun 20157:00 amRNSPreliminary Results
5th Jun 20157:00 amRNSPlacing to raise £1.54 million
19th May 20152:35 pmRNSAppointment of broker
15th Apr 20157:01 amRNSFDA Results
7th Apr 20157:00 amRNSShares Issued for Exercised Warrants
2nd Apr 20157:01 amRNSFirst Day of Dealings of Amphion Partner Company
24th Mar 20153:28 pmRNSIssue of Shares
20th Mar 20157:01 amRNSMotif Bio Ltd Update Re Intention to Float
26th Feb 20157:00 amRNSIssue of Equity
9th Feb 20157:00 amRNSDirector/PDMR Shareholding
2nd Feb 20154:18 pmRNSReissue: Partner Company's Intention to Float
2nd Feb 20158:00 amRNSPartner Company's Intention to Float on AIM
22nd Jan 20151:15 pmRNSDirector/PDMR Shareholding
19th Jan 20157:00 amRNSLandmark Acquisition & Update by Partner Company
6th Jan 20157:00 amRNSDataTern Receives Favourable Appeal Ruling
24th Sep 20147:00 amRNSDirectors' Dealings
19th Sep 20147:00 amRNSHalf Yearly Report
9th Sep 20147:00 amRNSAdditional Draws on Loan Facility
28th Aug 20147:00 amRNSDirectorate Change
7th Aug 20144:51 pmRNSResult of AGM and EGM
10th Jul 20149:10 amRNSDirectors' Dealings
8th Jul 20147:00 amRNSAmphion Partner Motif Can Help Solve Health Crisis
20th Jun 20147:00 amRNSNotice of EGM
18th Jun 20147:00 amRNSFinal Results
5th Jun 20147:00 amRNSNew Loan Facility
14th Apr 20147:00 amRNSAppeal Ruling
7th Apr 20145:03 pmRNSDirector/PDMR Shareholding
28th Jan 20147:00 amRNSConvertible Promissory Note Extension
12th Dec 20137:00 amRNSUpdate on Covertible Promissory Note
13th Nov 20134:33 pmRNSDirector/PDMR Shareholding
13th Nov 20137:00 amRNSPartner Company Update
16th Oct 20137:02 amRNSPartner Company IPO
24th Sep 20137:00 amRNSHalf Yearly Report
12th Sep 20137:02 amRNSPartner company Kromek seeks IPO on AIM
13th Aug 20135:16 pmRNSResult of AGM
1st Jul 201312:02 pmRNSDirector/PDMR Shareholding
28th Jun 20137:00 amRNSFinal Results
18th Apr 20137:00 amRNSDirector/PDMR Shareholding
17th Apr 20137:00 amRNSTrading Statement
28th Mar 20137:02 amRNSChange of Adviser
19th Dec 20127:00 amRNSHolding(s) in Company
13th Dec 20127:00 amRNSFundraising
5th Dec 20127:00 amRNSAmphion announces new partnership with Motif
3rd Oct 20127:00 amRNSDirector/PDMR Shareholding
28th Sep 20124:24 pmRNSDirector/PDMR Shareholding
19th Sep 20127:00 amRNSHalf Yearly Report
29th Aug 20127:00 amRNSUpdate - patent litigation
27th Jul 20127:00 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.